Davids Joseph News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Davids joseph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Davids Joseph Today - Breaking & Trending Today
Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement of 1,390,000 common shares of the Company to raise … NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. (CSE:AVBT) (“ Avisa ” or the “ Company ”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement (the “ Offering ”) of 1,390,000 common shares (“ Common Shares � ....